SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001385508-22-000061
Filing Date
2022-05-17
Accepted
2022-05-17 16:02:13
Documents
1
Period of Report
2022-05-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_165281769689341.html 4  
1 FORM 4 wf-form4_165281769689341.xml 4 3522
  Complete submission text file 0001385508-22-000061.txt   5173
Mailing Address C/O CORNERSTONE THERAPEUTICS INC. 1255 CRESCENT GREEN DRIVE, SUITE 250 CARY NC 27518
Business Address 919-678-6611
Collard Craig A (Reporting) CIK: 0001363558 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38193 | Film No.: 22934385

Mailing Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401
Business Address 233 WILSHIRE BLVD SUITE 400 SANTA MONICA CA 90401 (310) 598-5410
OPIANT PHARMACEUTICALS, INC. (Issuer) CIK: 0001385508 (see all company filings)

IRS No.: 464744124 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations